Valuation : GI Dynamics, Inc.

Market Cap 440K 379K 356K 325K 611K 41.91M 615K 4.22M 1.64M 21.25M 1.65M 1.62M 70.37M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.82M 2.65M 2.42M 4.55M 312M 4.58M 31.42M 12.22M 158M 12.31M 12.05M 524M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 2025-08-04
Director of Finance/CFO 57 2025-07-31
Chief Tech/Sci/R&D Officer - 2023-03-31
Director TitleAgeSince
Director/Board Member - 2020-10-19
Director/Board Member - -
Director/Board Member 69 2023-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
1/28/21 Free

Chairman

1,384,483 0.4875%
1/28/21 Free

Chief Executive Officer

11,075,869 3.8998%

Financials

2019 2020
Net sales - -
Net income -17.33M -14.92M -14.01M -12.79M -24.03M -1.65B -24.2M -166M -64.61M -836M -65.08M -63.67M -2.77B -11.14M -9.59M -9M -8.22M -15.44M -1.06B -15.55M -107M -41.51M -537M -41.81M -40.9M -1.78B
Net Debt 2.89M 2.49M 2.33M 2.13M 4M 275M 4.03M 27.66M 10.76M 139M 10.84M 10.6M 461M 2.84M 2.44M 2.3M 2.1M 3.94M 270M 3.96M 27.2M 10.58M 137M 10.66M 10.43M 454M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock